NCT03735095 Endobronchial Ultrasound Guided Interstitial Photodynamic Therapy in Treating Patients With Locally Advanced Lung Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT03733587 GX-I7 With Cyclophosphamide in Patients With Metastatic or Recurrent Solid Tumors Status COMPLETED Phase PHASE1
NCT03707808 Intratumoral Injection of Autologous CD1c (BDCA-1)+ MyDC, Avelumab, and Ipilimumab Plus Systemic Nivolumab Status RECRUITING Phase PHASE1/PHASE2
NCT03680560 Study of ACTR T Cell Product in Combination With Trastuzumab in Subjects With HER2-Positive Advanced Solid Tumor Cancers Status TERMINATED Phase PHASE1
NCT03673787 A Trial of Ipatasertib in Combination With Atezolizumab Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03658785 Immunotherapy for the Treatment of Advanced Solid Tumor Status RECRUITING Phase PHASE1/PHASE2
NCT03654716 Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer Status COMPLETED Phase PHASE1
NCT03647163 Ph I/II Trial of Systemic VSV-IFNβ-NIS in Combination With Checkpoint Inhibitor Therapy in Patients With Select Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03644056 Dose-escalation Study of IMC-001 in Subject With Metastatic or Locally-advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT03641547 M6620 Plus Standard Treatment in Oesophageal and Other Cancer Status COMPLETED Phase PHASE1
NCT03637803 Live Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT03619616 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Dose of ZSP1603 in Healthy Adults Status COMPLETED Phase PHASE1
NCT03611595 Cabozantinib in Combination With 13-cis-Retinoic Acid in Children With Relapsed or Refractory Solid Tumors Status COMPLETED Phase PHASE1
NCT03602079 Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene Status COMPLETED Phase PHASE1/PHASE2